YEEHAW CANDIDATES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike who wrote (965)	1/13/2003 5:54:56 PM
From: Sergio H	Read Replies (1) of 23958

Mike, this thread's portfolio is intended to be "long term" although we try to highlight the trading opportunities that come up on the stocks we follow. Please feel free to give as much detail on any stocks that you're following and thanks for joining in. MDCO has been in our portfolio prior to the Replace 2 test results. We tend to profile stocks before they get to Briefing's In Play list as MDCO did this afternoon: <3:26PM New High Profile --The Medicines Co (MDCO) 17.62 +0.56: Shares of biopharmaceutical company break out above 52-wk high of $17.50 established Nov 18. This is one of the few names in the space to make a new one-year high in recent memory. The co's lead product, Angiomax, has been approved in the U.S. and other countries for use as an anticoagulant in patients undergoing coronary angioplasty. Although not profitable at this pt (projected loss for 2003 is $0.26 per share), MDCO expanded revs in the most recent qtr by 160%. For 2003, analysts expect revs to increase 123%. MDCO expected to post a profit of $0.73 in 2004 on rev growth of approx. 70%... Mkt-cap $690 mln; short interest 13%. >

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next